BURCON PROVIDES UPDATE ON CANOLA LICENSE & DEVELOPMENT AGREEMENT
04 Mars 2011 - 9:29PM
PR Newswire (Canada)
VANCOUVER, March 4 /CNW/ -- VANCOUVER, March 4 /CNW/ - Burcon
NutraScience Corporation (TSX: BU) announced today that the company
has amended the license and development agreement between Burcon,
Burcon NutraScience (MB) Corp. and Archer Daniels Midland Company
("ADM") to provide an extended development period for continued
research aimed at expanding the commercial value of Puratein(®) and
Supertein(™). Burcon and ADM have agreed to an amendment of the
license and development agreement to effectively provide a one-year
extension to March 1, 2012, to facilitate continued research.
Burcon's main research objective during the one-year term of this
amendment is to further the commercialization potential of Burcon's
canola protein products Puratein and Supertein, particularly with
respect to their unique functional and nutritional
characteristics. As such, Burcon will conduct research aimed
at refining its canola extraction and purification technologies,
develop new technologies as well as specialized canola protein
products. The amendment contemplates that Burcon may, at its
sole discretion and expense, engage a third party research
organization to conduct a joint research study, including human
clinical feeding trials, designed to investigate Supertein's
potential as a functional food ingredient. In particular, the
research would seek to develop evidence of Supertein's ability -
given its high cysteine content - to mitigate certain physiological
effects associated with metabolic syndrome. "Burcon has
focused on commercializing our CLARISOY(®) technology for the past
few years and now we are able to devote more resources toward our
canola protein technologies," commented Johann F. Tergesen,
president and COO of Burcon, adding, "We remain excited about the
potential for canola protein to earn an important share of the
protein ingredient industry as a result of its unique inherent
nutritional and functional characteristics."
About Burcon NutraScience Burcon is a leader in nutrition, health
and wellness in the field of functional, renewable plant proteins.
Since 1999, Burcon has developed a portfolio of composition,
application, and process patents originating from our core protein
extraction and purification technology. We are developing Puratein®
and Supertein™ canola protein isolates with unique functional and
nutritional attributes, and CLARISOY(®), a revolutionary soy
protein which is 100% soluble and completely transparent in acidic
solutions. Our team of highly specialized scientists and engineers
work from our own research facility to develop and optimize
environmentally sound technologies. To-date, our patent portfolio
consists of 151 issued patents in various countries, including 25
issued U.S. patents, and in excess of 250 additional pending patent
applications, 65 of which are U.S. patent applications. ON BEHALF
OF THE BOARD OF DIRECTORS "Johann F. Tergesen" Johann F. Tergesen
President and Chief Operating Officer The TSX has not reviewed and
does not accept responsibility for the adequacy of the content of
the information contained herein. This press release contains
forward-looking statements that involve risks and uncertainties.
These forward-looking statements relate to, among other things,
plans and timing for the introduction or enhancement of our
products, statements about future market conditions, supply and
demand conditions, and other expectations, intentions and plans
contained in this press release that are not historical fact. Our
expectations regarding the prospect for future success depend upon
our ability to develop and sell products, which we do not produce
today and cannot be sold without further research and development.
When used in this press release, the words "goal", "intend",
"believes" and "potential" and similar expressions, generally
identify forward-looking statements. These statements reflect our
current expectations. They are subject to a number of risks and
uncertainties. In light of the many risks and uncertainties
surrounding the development of a source of protein from canola
meal, you should understand that we cannot assure you that the
forward looking statements contained in this press release will be
realized. To view this news release in HTML formatting, please use
the following URL:
http://www.newswire.ca/en/releases/archive/March2011/04/c8232.html
p align="center"Jade Cheng, Chief Financial Officerbr/ Burcon
NutraScience Corporationbr/ (604) 733-0896 / (888) 408-7960
toll-freebr/ a href="mailto:jcheng@burcon.ca"jcheng@burcon.ca/a a
href="http://www.burcon.ca"www.burcon.ca/a/p
Copyright
Burcon NutraScience (TSX:BU)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Burcon NutraScience (TSX:BU)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024
Real-Time news about Burcon NutraScience Corporation (Toronto Stock Exchange): 0 recent articles
Plus d'articles sur Burcon Nutrascience Corporation